Session Information

  • WCLC 2021

    2021 World Conference on Lung Cancer

    Conference Program for 2021 the World Conference on Lung Cancer

    Presentation Date(s):  
    • September 8 - 14, 2021
    • Total Presentations: 1107

    All times listed are in Mountain Time MDT (UTC-6:00)

    PL - Plenary
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    FP - Featured Posters
    P - Posters
    WS - Workshops
    IS - Industry Symposium
    MTE - Meet the Expert
    BEDG - Brain Exchange Discussion Groups

Filter Results:

Show Only CME Accredited Sessions

  • +

    FP05 - Liquid Biopsy and Other Non-invasive Diagnostic Modalities

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters (Featured)
    • Track: Liquid Biopsy and Other Non-invasive Diagnostic Modalities
    • +

      FP05.02 - A Biomarker-Directed, Multi-Center Phase II Study of Molecular Response Adaptive Immuno-Chemotherapy in Lung Cancer

      00:00 - 00:00  |  Presenter: Valsamo Anagnostou

      • Abstract

      Loading...

    • +

      FP05.03 - Multiomic, Plasma-Only ctDNA NGS Assay Developed for Minimal Residual Disease (MRD) Detection in Early-Stage NSCLC

      00:00 - 00:00  |  Presenter: Jessica Kurata

      • Abstract

      Loading...

    • +

      FP05.04 - Robust Discrimination of Lung Cancer via Microbial DNA Detection and Machine Learning Classification

      00:00 - 00:00  |  Presenter: Eddie Adams

      • Abstract

      Loading...

    • +

      FP05.05 - A Prospective Observational Study of Osimertinib Using Plasma Concentrations in NSCLC With Acquired EGFR T790M Mutation

      00:00 - 00:00  |  Presenter: TAKU NAKAGAWA

      • Abstract

      Loading...

  • +

    FP06 - Management of Lung Cancer in the Era of COVID 19

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters (Featured)
    • Track: Management of Lung Cancer in the Era of COVID-19
    • +

      FP06.01 - Unexpected Aggressive Histological Component in Subsolid Lung Adenocarcinoma: Priority for Resection Without Delay

      00:00 - 00:00  |  Presenter: Masaya Yotsukura

      • Abstract

      Loading...

    • +

      FP06.02 - The Impact of The COVID-19 Pandemic on New Diagnoses of Lung Cancer: A 3-Year Review of an Irish Cancer Centre

      00:00 - 00:00  |  Presenter: Hailey Kathryn Carroll

      • Abstract

      Loading...

    • +

      FP06.03 - COVID-19: Does Thoracic Surgery Increase Mortality Rates during the Pandemic?

      00:00 - 00:00  |  Presenter: Maria Teresa Ruiz Tsukazan

      • Abstract

      Loading...

  • +

    FP07 - Mesothelioma, Thymoma and Other Thoracic Malignancies

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters (Featured)
    • Track: Mesothelioma, Thymoma and Other Thoracic Malignancies
    • +

      FP07.01 - The MDM2/p53 Axis is a Therapeutic Vulnerability in Malignant Pleural Mesothelioma

      00:00 - 00:00  |  Presenter: Lynn E Heasley

      • Abstract

      Loading...

    • +

      FP07.02 - Next Generation Sequencing Portrays Mutation Profilings of Malignant Pleural and Peritoneal Mesotheliomas

      00:00 - 00:00  |  Presenter: Jingquan Zhao

      • Abstract

      Loading...

    • +

      FP07.03 - Diagnostic Potential of Novel Mesothelioma-Specific MicroRNAs

      00:00 - 00:00  |  Presenter: Michaela B Kirschner

      • Abstract

      Loading...

    • +

      FP07.04 - Effect of Tumor Treating Fields (TTFields) on DNA Damage and The FA-BRCA DNA Repair Pathway in Mesothelioma

      00:00 - 00:00  |  Presenter: Eyal Dor-On

      • Abstract

      Loading...

    • +

      FP07.05 - DREAM3R: Durvalumab With Chemotherapy as First Line Treatment in Advanced Pleural Mesothelioma - A Phase 3 Randomised Trial

      00:00 - 00:00  |  Presenter: Anna Nowak

      • Abstract

      Loading...

  • +

    FP08 - Multimodality Management of Advanced Lung Cancer

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters (Featured)
    • Track: Multimodality of Advanced Lung Cancer
    • +

      FP08.01 - Lung Stereotactic Body Radiation Therapy for Treatment of Oligoprogressive and Oligorecurrent Metastatic Disease: A Multi-Center Analysis

      00:00 - 00:00  |  Presenter: Sibo Tian

      • Abstract

      Loading...

    • +

      FP08.02 - Artificial Neural Network-Based Tumour Recurrence Prediction in Non-Small Cell Lung Cancer Patients Following Radical Radiotherapy

      00:00 - 00:00  |  Presenter: Timothy Mitchell

      • Abstract

      Loading...

    • +

      FP08.03 - Outcomes With Multi-Disciplinary Management of Central Lung Tumors Treated With Percutaneous High-Dose-Rate Brachytherapy

      00:00 - 00:00  |  Presenter: Stephanie Mijin Yoon

      • Abstract

      Loading...

    • +

      FP08.04 - Tumour Spread Through Air Space (STAS) In Lung Metastases

      00:00 - 00:00  |  Presenter: Alberto Sandri

      • Abstract

      Loading...

  • +

    FP09 - Novel Therapeutics and Targeted Therapies

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters (Featured)
    • Track: Novel Therapeutics and Targeted Therapies
    • +

      FP09.01 - Mobocertinib in Platinum-Pretreated EGFR Exon 20 Insertion+ Metastatic NSCLC Patients With/Without Prior Anti-PD(L)-1 Therapy

      00:00 - 00:00  |  Presenter: Pasi A. Janne

      • Abstract

      Loading...

    • +

      FP09.02 - Mobocertinib (TAK-788) in EGFR Exon 20 Insertion+ Metastatic NSCLC: Patient-Reported Outcomes From EXCLAIM Extension Cohort

      00:00 - 00:00  |  Presenter: Maria Rosario García Campelo

      • Abstract

      Loading...

    • +

      FP09.03 - Phase II Randomized Trial to Evaluate Prednisone Taper With or Without Nintedanib for the Treatment of Radiation Pneumonitis

      00:00 - 00:00  |  Presenter: Zachary R Moore

      • Abstract

      Loading...

    • +

      FP09.04 - Impact of Brain Metastasis Status on Adverse Events (AEs) Requiring Dose Reduction Among Patients Receiving Lorlatinib

      00:00 - 00:00  |  Presenter: John F Murphy

      • Abstract

      Loading...

  • +

    FP10 - Palliative and Supportive Care

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters (Featured)
    • Track: Palliative and Supportive Care
    • +

      FP10.01 - The Efficacy of Immunotherapy in non-Small Cell Lung Cancer Patients with Uncommon Mutations: a Real World Research from Single Site

      00:00 - 00:00  |  Presenter: Ying Cheng

      • Abstract

      Loading...

  • +

    FP11 - Patient Advocacy

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters (Featured)
    • Track: Patient Advocacy
    • +

      FP11.01 - Sustaining and Accelerating Research in Rare Oncogene-Driven Lung Cancers: Lessons From The 2020 ROS1der Research Roundtable

      00:00 - 00:00  |  Presenter: Janet Freeman-Daily

      • Abstract

      Loading...

  • +

    FP12 - Predictive Tumor Based Assays/Biomarkers/Pathology

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters (Featured)
    • Track: Predictive Tumor Based Assays/ Biomarkers/ Pathology
    • +

      FP12.01 - PD-L1 Assessment in Cytology is Comparable to Histology in Predicting Treatment Response to Checkpoint Inhibitors in NSCLC

      00:00 - 00:00  |  Presenter: Sally CM Lau

      • Abstract

      Loading...

    • +

      FP12.02 - Pembrolizumab as a Monotherapy or in Combination With Platinum-Based Chemotherapy in NSCLC: Correlation With Blood Biomarkers

      00:00 - 00:00  |  Presenter: Liran Holtzman

      • Abstract

      Loading...

    • +

      FP12.03 - Associations of Urinary Biomarkers of Tobacco Toxicants With Lung Cancer Incidence in Smokers: The Multiethnic Cohort Study

      00:00 - 00:00  |  Presenter: Sungshim L Park

      • Abstract

      Loading...

    • +

      FP12.04 - Obesity is Associated With Greater Overall Survival in Patients With Metastatic NSCLC Receiving First-Line Pembrolizumab

      00:00 - 00:00  |  Presenter: Findlay David Thomson

      • Abstract

      Loading...

    • +

      FP12.05 - The Intrinsic Limitation and Clinical Impact of Mutant Allele-Specific Real-Time PCR-Based EGFR Mutation Assay in NSCLC

      00:00 - 00:00  |  Presenter: Chia-I Shen

      • Abstract

      Loading...

    • +

      FP12.06 - Solid Subtype Predicts Early Bone Metastases in Sensitive EGFR-Mutated Lung Adenocarcinoma Patients After Surgery

      00:00 - 00:00  |  Presenter: Anning Xiong

      • Abstract

      Loading...

    • +

      FP12.07 - Clinico-demographic Factors, EGFR status and their association with Stage at Diagnosis in Lung Adenocarcinoma Patients

      00:00 - 00:00  |  Presenter: Joshua E Herman

      • Abstract

      Loading...

    • +

      FP12.08 - Lung Adenocarcinomas with ROS1 Rearrangement show Diffuse Strong ROS1 Immunohistochemical Staining

      00:00 - 00:00  |  Presenter: Timothy Fielder

      • Abstract

      Loading...

  • +

    FP13 - Screening and Early Detection

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters (Featured)
    • Track: Screening and Early Detection
    • +

      FP13.01 - Assessment of the Fear of COVID-19 and Its Impact on Lung Cancer Screening Participation Among the Korean General Population

      00:00 - 00:00  |  Presenter: Linh Thuy Duong

      • Abstract

      Loading...

    • +

      FP13.02 - Costal Pleura-attached Noncalcified Nodules Newly Seen on Annual Low-Dose CT Screenings

      00:00 - 00:00  |  Presenter: Yeqing Zhu

      • Abstract

      Loading...

    • +

      FP13.03 - The Impact of the COVID-19 Pandemic on Lung Cancer Screening Programs in the United States

      00:00 - 00:00  |  Presenter: Jennifer C. King

      • Abstract

      Loading...

    • +

      FP13.04 - CHECK Lung Protocol: CT Lung Cancer Screening is Useful to Adjuvant Comorbid Diseases Diagnosis

      00:00 - 00:00  |  Presenter: Paulo Alfredo Casanova Schulze

      • Abstract

      Loading...

  • +

    FP14 - Small Cell Lung Cancer/NET

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters (Featured)
    • Track: Small Cell Lung Cancer/ NET
    • +

      FP14.01 - A Phase 1b/2 Study of Autologous Dendritic Cell Vaccination in Combination With Atezolizumab in Patients With Small Cell Lung Cancer (SCLC)

      00:00 - 00:00  |  Presenter: Maria Gonzalez-Cao

      • Abstract

      Loading...

    • +

      FP14.02 - Small Cell Lung Carcinoma’s Clinical Versatility Is a Manifestation of Its Shape-Shifting Cellular Programs

      00:00 - 00:00  |  Presenter: Mohamed E. Abazeed

      • Abstract

      Loading...

    • +

      FP14.03 - Diagnostic Accuracy in Central Pulmonary Carcinoid tumors is Dependent of Biopsy Size

      00:00 - 00:00  |  Presenter: Dwayne Naves

      • Abstract

      Loading...